Publications by authors named "L Muderspach"
Article Synopsis
- * Cervical cancer had the highest representation among AYA patients at 25.3%, with notable increases in annual rates for several female cancers, particularly colorectal cancer which saw the largest increase at 4.1%.
- * The findings indicate a rising trend of AYA patients diagnosed with certain cancers related to obesity, especially in the three most common gynecologic cancers: ovary, uterus, and cervix.
Objective: To assess the prognostic performance of the 2023 International Federation of Gynecology and Obstetrics (FIGO) endometrial cancer staging schema.
Methods: This retrospective cohort study queried the Commission-on-Cancer's National Cancer Database. Study population was 129,146 patients with stage I-IV endometrial cancer per the 2009 FIGO staging schema.
Study Objective: This study aimed to determine the effect of the implementation of the Enhanced Recovery After Surgery (ERAS) protocol among patients receiving minimally invasive gynecologic surgery.
Design And Setting: This retrospective cohort study was performed in a tertiary care hospital.
Patients: A total of 328 females who underwent minimally invasive gynecologic surgeries requiring at least one overnight stay at Keck Hospital of University of Southern California (USC), California, USA, from 2016 to 2020 were included in this study.
Objective: Failure-to-rescue, defined as mortality following a perioperative complication, is a perioperative quality indicator studied in various surgeries, but not in vulvar cancer surgery. The objective of this study was to assess failure-to-rescue in patients undergoing surgical therapy for vulvar cancer.
Methods: This cross-section study queried the National Inpatient Sample.
Background: Eribulin a microtubule targeting agent and analog of Halichondrin B, a natural product isolated from marine sponge H. okadai, has proven clinical efficacy in metastatic pretreated breast cancer and liposarcoma. We conducted a 2-stage Phase II study of eribulin in patients with advanced/recurrent cervical cancer to examine its clinical activity and evaluate biomarkers for predictors of response.
View Article and Find Full Text PDF